Discrepancy between Angina and Ischemia Repeats in Peripheral Artery Disease

Three randomized studies showed exercising significantly improves 6-minute walk outcomes in patients with peripheral artery disease (PAD). However, many participants randomized to exercise did not perceive changes, and sometimes even got worse. 

La discrepancia entre angina e isquemia se repiten en enfermedad periférica

These findings suggest a significant discrepancy between objective and perceived change in walking ability among PAD patients.  

400 patients with peripheral artery disease randomized to exercise (n=205) vs control (n=199) completed a 6-minute walk test and a questionnaire about perceived claudication. Both tests were repeated 6 months after randomization.

Exercising improved significantly 6-minute walking distance almost 40 meters vs. baseline (p<0.001). 

Many patients perceived no improvement in walking ability after 6 months. This was true for the control group, with – 6.5 meters vs baseline (p<0.001), as opposed to the exercise group, which added 26.8 meters (p<0.001).

Another group perceived their situation had significantly worsened vs. baseline. Again, this was true for the control group, with – 27.3 meters, but not for the exercise group, with + 18.4 meters vs. baseline. 


Read also: Abdominal Aortic Aneurysm during the Pandemic: Should They Be Operated or Deferred?


Having set a walking pace, PAD patients will often report no improvement at follow up, which might tilt the scales for revascularization. It seems important to be able to objectively measure walking ability at baseline and follow up to be able to make objective decisions. 

The coronaries have shown angina and ischemia do not walk hand in hand. Now peripheral vascular disease shows similar discrepancy between symptoms and objective test outcomes. 

Conclusion

Exercising significantly improves walking distance in PAD patients. However, many patients do not perceive this change, and some even feel they get worse. 

JAHA-120-017609

Original Title: Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy.

Reference: Mary M. McDermott et al. J Am Heart Assoc. 2021;10:e017609. DOI: 10.1161/JAHA.120.017609.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...